查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1251521

儿科疫苗市场，按疫苗类型、技术、类型、分销渠道、地区 - 规模、份额、展望、机会分析，2023-2030 年

Pediatric Vaccines Market, By Vaccine Type, By Technology, By Type, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 190 Pages | 商品交期: 2-3个工作天内

价格
简介目录

疫苗接种是公共医疗保健计划之一，可在十年内预防数千人死亡、数百万人患病并节省数十亿美元。 免疫接种是保护儿童免受疾病、残疾和死亡（包括癌症）侵害的安全有效方法。 在大流行和其他突发公共卫生事件期间，保持定期接种疫苗以防止进一步爆发非常重要。 疫苗根据年龄段分为成人疫苗和儿童疫苗。 小儿疫苗是在出生时第一次接种。 然后在出生后 6 週，第 3 剂在出生后 10 週，最后一剂在出生后 14 週。 这种疫苗可预防脊髓灰质炎病毒，这是一种影响神经系统并可能导致完全瘫痪的高度传染性疾病。

市场动态

疫苗监管审批的增加预计将在预测期内推动市场增长。 例如，2022 年 6 月 18 日，美国疾病控制与预防中心 (CDC) 批准 6 个月及以上的婴儿接种 COVID-19。 这意味着美国又有 2000 万五岁以下儿童接种了疫苗。 对于 5 岁以下的儿童，有两种疫苗可供选择。 为 6 个月至 4 岁的儿童提供 3 剂辉瑞 COVID-19 疫苗，剂量为 3 微克。 建议 6 个月至 5 岁儿童接种 2 剂 Moderna COVID-19 疫苗，剂量为 25 微克。

市场参与者正专注于增加研发活动，以生产采用各种技术对抗 COVID-19 等传染病的疫苗。 例如，2022 年 6 月，跨国製药和生物技术公司辉瑞日本公司和生物技术公司 BioNTech SE 将评估两种 COVID-19 候选疫苗的安全性、免疫原性和耐受性，单价和二价。 COVID-19 疫苗和候选疫苗的组合针对相关 Omicron BA.1 突变体的刺突蛋白。 2/3 期试验数据显示，与公司目前的 COVID-19 疫苗相比，两种候选疫苗的 Omicron 适应性加强剂量显着增强了对 Omicron BA.1 的免疫反应。 这种强大的免疫反应在 30mcg 和 60mcg 的两个研究剂量水平得到证实。 基于 BioNTech 的专有 mRNA 技术，辉瑞 BioNTech COVID-19疫苗由 BioNTech 和辉瑞公司共同开发。

这项研究的主要特点

  • 本报告对全球儿科疫苗市场进行了深入分析，提供了以 2022 年为基准年的预测期 (2023-2030) 的市场规模和復合年增长率 (CAGR%)。我在这里.
  • 它揭示了各个细分市场的潜在收入机会，并描述了该市场具有吸引力的投资建议矩阵。
  • 它还提供有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
  • 根据公司亮点、产品组合、主要亮点、财务业绩和战略等参数，对全球儿科疫苗市场主要参与者的概况进行分析。
  • 参与本研究的主要公司包括 GlaxoSmithKline Plc.、Merck & Co., Inc.、Pfizer Inc.、Sanofi S.A.、Panacea Biotec、Zydus Cadila、Emergent BioSolutions Inc.、Serum Institute of India Pvt Ltd.、Bharat Biotech 和 Indian Immunologicals Ltd.。
  • 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 《全球儿科疫苗市场报告》面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以通过用于分析全球儿科疫苗市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

  • 调查目的
  • 先决条件
  • 缩写说明

第二章市场范围

  • 报告内容
    • 市场定义和范围
  • 执行摘要
    • 市场概况：按疫苗类型分类
    • 市场概况：按技术分类
    • 市场概况：按类型分类
    • 市场概况：按分销渠道
    • 市场概况：按地区
  • 连贯机会图 (COM)

第 3 章市场动态、法规和趋势分析

  • 市场动态
    • 司机
    • 约束因素
    • 市场吸引力分析
    • 市场机会
  • 产品发布
  • 合併/收购/合作
  • 监管准则和合规性
  • 主要发展
  • 害虫分析
  • 技术/情况
  • 对 PORTER 的分析
  • 价格分析 (2021)

第 4 章全球儿科疫苗市场——冠状病毒 (COVID-19) 大流行的影响

  • 经济影响
  • COVID-19 流行病学
  • 对供需的影响

第 5 章全球儿科疫苗市场，按疫苗类型分列，2017-2030

  • 肺炎球菌疫苗
  • 百白破疫苗
  • 轮状病毒疫苗
  • MMR 疫苗
  • 脊髓灰质炎疫苗
  • 流感疫苗
  • 乙型肝炎疫苗
  • 脑膜炎球菌疫苗
  • 乙肝疫苗
  • 水痘（水痘）疫苗

第 6 章全球儿科疫苗市场，按技术分类，2017-2030

  • 活疫苗或减毒疫苗
  • 灭活□□或灭活疫苗
  • 类毒素疫苗
  • 结合疫苗
  • 亚单位疫苗
  • 重组疫苗

第 7 章全球儿科疫苗市场，按类型，2017-2030

  • 单价疫苗
  • 多价疫苗

第 8 章全球儿科疫苗市场，按分销渠道，2017-2030

  • 政府
  • 私人

第 9 章全球儿科疫苗市场，按地区划分，2017-2030

  • 北美
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地区
  • 欧洲
  • 英国
  • 德国
  • 意大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 东盟
  • 澳大利亚
  • 韩国
  • 其他亚太地区
  • 中东
  • 海湾合作委员会
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中非
  • 南非

第10章竞争格局

  • GlaxoSmithKline Plc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Panacea Biotec
  • Zydus Cadila
  • Emergent BioSolutions Inc.
  • Serum Institute of India Pvt. Ltd.
  • Bharat Biotech
  • Indian Immunologicals Ltd.

第 11 章章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI1708

Immunizations is one of the public healthcare program for vaccination that prevents thousands of deaths, millions of cases of disease, and saves billions of dollars per decade. Immunizations are a safe, and effective way to protect children from disease including cancers, disability, and death. It is important during a pandemic or other public health emergency to maintain routine immunizations in order to prevent further outbreaks. There are various types of vaccines based on age group that include adult vaccines and pediatric vaccines. The pediatric vaccine is the first dose that is taken at birth. The next dose is taken when the child is 6 weeks old, the third dose at 10 weeks old, and the last dose at 14 weeks old. This vaccine protects against the poliovirus that is a highly infectious disease that invades the nervous system, and can lead to total paralysis.

Market Dynamics

Increasing approval of vaccines by regulatory authorities is expected to drive the market growth over the forecast period. For instance, on June 18, 2022, the Centers for Disease Control and Prevention (CDC) has approved COVID-19 vaccination for young children of age least 6 months old that means 20 million children, in the U.S., that are under 5 years are newly eligible for vaccination. For children under 5, there are two vaccines available. The three-dose Pfizer COVID-19 vaccine is provided to children 6 months to 4 years of age at a 3 microgram dosage. The two-dose Moderna COVID-19 vaccine is recommended for children of age 6 months to 5 years at a dose of 25 micrograms.

Key market players are focusing on increasing research and development activities for producing vaccines that employs various technologies to combat infections such as COVID-19 and others. For instance, in June 2022, Pfizer Inc., a multinational pharmaceutical and biotechnology, and BioNTech SE, a biotechnology company, announced positive data evaluating the safety, immunogenicity, and tolerability, of two Omicron-adapted COVID-19 vaccine candidates: one monovalent and the other bivalent. A combination of the Pfizer-BioNTech COVID-19 Vaccine and a vaccine candidate targets the spike protein of the Omicron BA.1 variant of concern. Data from the Phase 2/3 trial showed that a booster dose of both Omicron-adapted vaccine candidates has substantially higher immune response against Omicron BA.1, as compared to the companies' current COVID-19 vaccine. The robust immune response was seen in two investigational dose levels, 30 µg and 60 µg. The Pfizer-BioNTech COVID-19 Vaccine that is based on BioNTech's proprietary mRNA technology was developed by both BioNTech and Pfizer Inc.

Key features of the study:

  • This report provides in-depth analysis of the global pediatric vaccines market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global Pediatric Vaccines Market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study GlaxoSmithKline Plc., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Panacea Biotec, Zydus Cadila, Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech, and Indian Immunologicals Ltd.
  • Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global pediatric vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric vaccines market

Detailed Segmentation:

  • Global Pediatric Vaccines Market, By Vaccine Type:
    • Pneumococcal Vaccine
    • DTP Vaccine
    • Rotavirus Vaccine
    • MMR Vaccine
    • Polio Vaccine
    • Influenza Vaccine
    • Hepatitis B Vaccine
    • Meningococcal Vaccine
    • Hib Vaccine
    • Varicella Vaccine
  • Global Pediatric Vaccines Market, By Technology :
    • Live or Attenuated Vaccine
    • Inactivated or Killed Vaccine
    • Toxoid Vaccine
    • Conjugate Vaccine
    • Subunit Vaccine
    • Recombinant Vaccine
  • Global Pediatric Vaccines Market By Type:
    • Monovalent Vaccine
    • Multivalent Vaccine
  • Global Pediatric Vaccines Market By Distribution Channel:
    • Government
    • Private
  • Global Pediatric Vaccines Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Type:
    • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • GlaxoSmithKline Plc.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Sanofi S.A.
    • Panacea Biotec
    • Zydus Cadila
    • Emergent BioSolutions Inc.
    • Serum Institute of India Pvt. Ltd.
    • Bharat Biotech
    • Indian Immunologicals Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Vaccine Type
    • Market Snapshot, By Technology
    • Market Snapshot, By Type
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Attractiveness Analysis
    • Market Opportunities
  • Product Launches
  • Merger, Acquisition, and Collaborations
  • Regulatory Guideline and Compliances
  • Key Developments
  • PEST Analysis
  • Technology Landscape
  • PORTER's Analysis
  • Pricing Analysis (2021)

4. Global Pediatric Vaccines Market- Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Pediatric Vaccines Market, By Vaccine Type, 2017-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Pneumococcal Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • DTP Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Rotavirus Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • MMR Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Polio Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Influenza Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Hepatitis B Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Meningococcal Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Hib Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Varicella Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Pediatric Vaccines Market, By Technology, 2017-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Live or Attenuated Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Inactivated or Killed Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Toxoid Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Conjugate Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Subunit Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Recombinant Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Pediatric Vaccines Market, By Type, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segments Trends
  • Monovalent Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Multivalent Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Pediatric Vaccines Market, By Distribution Channel, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segments Trends
  • Government
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Private
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Pediatric Vaccines Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • GlaxoSmithKline Plc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi S.A.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Panacea Biotec
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zydus Cadila
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Emergent BioSolutions Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Serum Institute of India Pvt. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bharat Biotech
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Indian Immunologicals Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

11. Section

  • Research Methodology
  • About Us